BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34543632)

  • 1. Low molecular weight chondroitin sulfate ameliorates pathological changes in 5XFAD mice by improving various functions in the brain.
    Zhao N; Wu L; Zhang X; Jiang W; Wang F
    Neuropharmacology; 2021 Nov; 199():108796. PubMed ID: 34543632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of low molecular weight chondroitin sulfate on amyloid beta (Aβ)-induced damage in vitro and in vivo.
    Zhang Q; Li J; Liu C; Song C; Li P; Yin F; Xiao Y; Li J; Jiang W; Zong A; Zhang X; Wang F
    Neuroscience; 2015 Oct; 305():169-82. PubMed ID: 26254241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tianma-Gouteng pair ameliorates the cognitive deficits on two transgenic mouse models of Alzheimer's disease.
    Zhong M; Xu QQ; Hu Z; Yang W; Lin ZX; Xian YF
    J Ethnopharmacol; 2024 Jun; 328():118113. PubMed ID: 38548119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight chondroitin sulfate attenuated injury by inhibiting oxidative stress in amyloid β-treated SH-SY5Y cells.
    Zhang Q; Na Z; Cheng Y; Wang F
    Neuroreport; 2018 Sep; 29(14):1174-1179. PubMed ID: 29985831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice.
    Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y
    Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
    Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
    J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease.
    Liu S; Tang SQ; Cui HJ; Yin S; Yin M; Zhao H; Meng LH; Wang ZJ; Lu Y
    J Pharmacol Sci; 2016 Sep; 132(1):92-99. PubMed ID: 27671351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.
    Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG
    CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1-42)-Induced Neuroinflammation in Mouse Models of Alzheimer's Disease.
    Trojan E; Tylek K; Schröder N; Kahl I; Brandenburg LO; Mastromarino M; Leopoldo M; Basta-Kaim A; Lacivita E
    Mol Neurobiol; 2021 Dec; 58(12):6203-6221. PubMed ID: 34468933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
    Bai Y; Ma X
    Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciproxifan improves cholinergic transmission, attenuates neuroinflammation and oxidative stress but does not reduce amyloid level in transgenic mice.
    Mani V; Jaafar SM; Azahan NSM; Ramasamy K; Lim SM; Ming LC; Majeed ABA
    Life Sci; 2017 Jul; 180():23-35. PubMed ID: 28501482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of spatial memory in 5xFAD mice by targeting cholinesterases, oxidative stress and inflammatory signaling using 2-(hydroxyl-(2-nitrophenyl)methyl)cyclopentanone.
    Ullah R; Ali G; Subhan F; Khan A; Ahsan Halim S; Naveed M; Kalsoom S; Al-Harrasi A
    Int Immunopharmacol; 2021 Nov; 100():108083. PubMed ID: 34478946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
    Sadleir KR; Popovic J; Vassar R
    J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.